These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 15227673

  • 1. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. I. Preparation and characterization.
    Kempen DH, Lu L, Zhu X, Kim C, Jabbari E, Dhert WJ, Currier BL, Yaszemski MJ.
    J Biomed Mater Res A; 2004 Aug 01; 70(2):283-92. PubMed ID: 15227673
    [Abstract] [Full Text] [Related]

  • 2. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH, Lu L, Zhu X, Kim C, Jabbari E, Dhert WJ, Currier BL, Yaszemski MJ.
    J Biomed Mater Res A; 2004 Aug 01; 70(2):293-302. PubMed ID: 15227674
    [Abstract] [Full Text] [Related]

  • 3. Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate).
    Kempen DH, Lu L, Kim C, Zhu X, Dhert WJ, Currier BL, Yaszemski MJ.
    J Biomed Mater Res A; 2006 Apr 01; 77(1):103-11. PubMed ID: 16392139
    [Abstract] [Full Text] [Related]

  • 4. In vitro degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds.
    Hedberg EL, Shih CK, Lemoine JJ, Timmer MD, Liebschner MA, Jansen JA, Mikos AG.
    Biomaterials; 2005 Jun 01; 26(16):3215-25. PubMed ID: 15603816
    [Abstract] [Full Text] [Related]

  • 5. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2009 Nov 01; 74(1):340-9. PubMed ID: 19717287
    [Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
    He JT, Tao XM, Mo W, Song HY.
    Yao Xue Xue Bao; 2006 Jan 01; 41(1):12-8. PubMed ID: 16683521
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T.
    Eur J Pharm Biopharm; 2008 Feb 01; 68(2):214-23. PubMed ID: 17651954
    [Abstract] [Full Text] [Related]

  • 10. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L, Chaw CS, Yang YY, Moochhala SM, Zhao B, Ng S, Heller J.
    Biomaterials; 2004 Jul 01; 25(16):3275-82. PubMed ID: 14980422
    [Abstract] [Full Text] [Related]

  • 11. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
    Hsu YY, Hao T, Hedley ML.
    J Drug Target; 1999 Dec 01; 7(4):313-23. PubMed ID: 10682910
    [Abstract] [Full Text] [Related]

  • 12. Production of microspheres with surface amino groups from blends of Poly(Lactide-co-glycolide) and Poly(epsilon-CBZ-L-lysine) and use for encapsulation.
    Zheng J, Hornsby PJ.
    Biotechnol Prog; 1999 Dec 01; 15(4):763-7. PubMed ID: 10441368
    [Abstract] [Full Text] [Related]

  • 13. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S, Janoria KG, Mitra AK.
    J Control Release; 2005 Nov 28; 108(2-3):282-93. PubMed ID: 16229919
    [Abstract] [Full Text] [Related]

  • 14. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
    Gasparini G, Kosvintsev SR, Stillwell MT, Holdich RG.
    Colloids Surf B Biointerfaces; 2008 Feb 15; 61(2):199-207. PubMed ID: 17919891
    [Abstract] [Full Text] [Related]

  • 15. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite.
    Ho ML, Fu YC, Wang GJ, Chen HT, Chang JK, Tsai TH, Wang CK.
    J Control Release; 2008 Jun 04; 128(2):142-8. PubMed ID: 18436324
    [Abstract] [Full Text] [Related]

  • 16. Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization.
    Khang G, Cho JC, Lee JW, Rhee JM, Lee HB.
    Biomed Mater Eng; 1999 Jun 04; 9(1):49-59. PubMed ID: 10436853
    [Abstract] [Full Text] [Related]

  • 17. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S, Tros de Ilarduya C.
    Eur J Pharm Biopharm; 2006 Jun 04; 63(2):188-97. PubMed ID: 16697172
    [Abstract] [Full Text] [Related]

  • 18. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
    Saxena V, Sadoqi M, Shao J.
    Int J Pharm; 2004 Jul 08; 278(2):293-301. PubMed ID: 15196634
    [Abstract] [Full Text] [Related]

  • 19. Fabrication of biodegradable spheroidal microparticles for drug delivery applications.
    Heslinga MJ, Mastria EM, Eniola-Adefeso O.
    J Control Release; 2009 Sep 15; 138(3):235-42. PubMed ID: 19467275
    [Abstract] [Full Text] [Related]

  • 20. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N, Wu XS, Li JK.
    Pharm Res; 1999 Sep 15; 16(9):1430-5. PubMed ID: 10496661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.